21 CFR 520.2345f

§ 520.2345f Tetracycline phosphate complex and sodium novobiocin capsules.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.2345f, § 520.2345f Tetracycline phosphate complex and sodium novobiocin capsules, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87349
Permanent ID: ys:prov:87349@1
SHA-256: e067a2b4638da8c7cd1116693d676e4fe6655c4e9c8b330efd89a0f06ed71e7c

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each capsule contains the equivalent of 60 milligrams of tetracycline hydrochloride and 60 milligrams of novobiocin. (b) Sponsor. No. 054771 in § 510.600(c) of this chapter. (c) Conditions of use in dogs—(1) Amount. 10 milligrams of each antibiotic per pound of body weight (1 capsule for each 6 pounds) every 12 hours. (2) Indications for use. Treatment of acute or chronic canine respiratory infections such as tonsillitis, bronchitis, and tracheobronchitis when caused by pathogens susceptible to tetracycline and/or novobiocin, such as Staphylococcus spp. and Escherichia coli. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.